Cambridge Investment Research Advisors
BCRX icon

Cambridge Investment Research Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio BCRX Stock Details BCRX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$170K Buy
2022
Q1 		– Sell
2021
Q4 		$394K Buy
2021
Q3 		$408K Sell
2021
Q2 		$526K Sell
2021
Q1 		$491K Buy
2020
Q4 		$314K Buy
2020
Q3 		$124K Sell
2020
Q2 		$254K Buy